Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Analytical Biochemistry|February 11, 2003
Time-minimized determination of ribosome and tRNA levels in bacterial cells using flow field-flow fractionationCecilia Arfvidsson, Karl Gustav Wahlund
Bioanalysis|July 28, 2020
Giving patients choices: AstraZeneca's evolving approach to patient-centric samplingChristopher Bailey, Cecilia Arfvidsson, Lynsey Woodford, et al.
Bioanalysis|September 2, 2021
High-sensitivity workflow for LC-MS-based analysis of GalNAc-conjugated oligonucleotides: a case studyAaron R Ledvina, Matthew Ewles, Paul Severin, et al.
Biotechnology Progress|June 8, 2002
Expression of double Vitreoscilla hemoglobin enhances growth and alters ribosome and tRNA levels in Escherichia coliViktoria Roos, Charlotte I J Andersson, Cecilia Arfvidsson, et al.
Biotechnology Letters|October 24, 2003
Enhanced ribosome and tRNA contents in Escherichia coli expressing a truncated Vitreoscilla hemoglobin mutant analyzed by flow field-flow fractionationCharlotte I J Andersson, Cecilia Arfvidsson, Pauli T Kallio, et al.
Drugs in R&D|June 2, 2018
Pharmacokinetics of the Oral Selective CXCR2 Antagonist AZD5069: A Summary of Eight Phase I Studies in Healthy VolunteersMarie Cullberg, Cecilia Arfvidsson, Bengt Larsson, et al.
Bioanalysis|August 2, 2017
AstraZeneca and Covance Laboratories Clinical Bioanalysis Alliance: an evolutionary outsourcing modelCecilia Arfvidsson, Paul Severin, Victoria Holmes, et al.
Drug Design, Development and Therapy|December 10, 2019
Safety, pharmacokinetics and pharmacodynamics of the selective glucocorticoid receptor modulator AZD7594, following inhalation in healthy Japanese volunteersSusanne Prothon, Ulrika Wählby Hamrén, Ulrika Tehler, et al.
Pageof 3